Technical Analysis for CPH - Cipher Pharmaceuticals Inc.

Grade Last Price % Change Price Change
grade C 1.34 0.00% 0.000
CPH closed unchanged on Tuesday, September 17, 2019, on approximately normal volume.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Down
See historical CPH trend table...

Date Alert Name Type % Chg
Inside Day Range Contraction 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Upper Bollinger Band Walk Strength -7.59%
Above Upper BB Strength -7.59%
Overbought Stochastic Strength -7.59%
Upper Bollinger Band Touch Strength -7.59%
Expansion Breakout Bullish Swing Setup -8.84%
Pocket Pivot Bullish Swing Setup -8.84%
Above Upper BB Strength -8.84%

Older signals for CPH ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Cipher Pharmaceuticals Inc. is a specialty pharmaceutical dermatology company. The Company has a portfolio of commercial and late-stage products. It operates in the specialty pharmaceuticals segment. It acquires products and compounds for treatment of various medical needs. Its commercial product portfolio includes ABSORICA; SITAVIG; NUVAIL; BIONECT; CLN8; INOVA; PRO:12 MOUSSE; AL12; LOTION UMECTA; ACLARO; EPURIS; VANIQA; ACTIKERALL; BETEFLAM; LIPOFEN; CONZIP, and DURELA. Its products treat indications, such as severe nodular acne, recurrent herpes labialis, nail dystrophy, dermal ulcers, mild/moderate onychomycosis, acne, dry skin, keratosis, hyperpigmentation, hyperkeratotic actinic keratosis and high cholesterol. Its pipeline of late-stage products includes DERMADEXIN, BETEFLAM PATCH, SITAVIG, PRURIDEXIN, OZENOXACIN, CF101 for plaque psoriasis, CF101 for rheumatoid arthritis, ASF-1096 and NANOLIPOLEE-007. It operates in Canada and the United States.
Medicine RTT Organ Systems Psoriasis Acne Actinic Keratosis Rheumatoid Arthritis
Is CPH a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.44
52 Week Low 1.11
Average Volume 21,136
200-Day Moving Average 1.5207
50-Day Moving Average 1.254
20-Day Moving Average 1.3195
10-Day Moving Average 1.364
Average True Range 0.0683
ADX 36.48
+DI 25.7734
-DI 12.9808
Chandelier Exit (Long, 3 ATRs ) 1.2951
Chandelier Exit (Short, 3 ATRs ) 1.3549
Upper Bollinger Band 1.4384
Lower Bollinger Band 1.2006
Percent B (%b) 0.59
BandWidth 18.021978
MACD Line 0.0393
MACD Signal Line 0.0353
MACD Histogram 0.004
Fundamentals Value
Market Cap 35.67 Million
Num Shares 26.6 Million
EPS -1.34
Price-to-Earnings (P/E) Ratio -1.00
Price-to-Sales 2.68
Price-to-Book 7.24
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.400
Resistance 3 (R3) 1.407 1.393 1.390
Resistance 2 (R2) 1.393 1.378 1.390 1.387
Resistance 1 (R1) 1.367 1.369 1.360 1.360 1.383
Pivot Point 1.353 1.353 1.350 1.350 1.353
Support 1 (S1) 1.327 1.338 1.320 1.320 1.297
Support 2 (S2) 1.313 1.329 1.310 1.293
Support 3 (S3) 1.287 1.313 1.290
Support 4 (S4) 1.280